Adaptive Dose-Staged Stereotactic Ablative Body Radiotherapy for Treatment of Large Central NSCLC Lung Tumors: A Dosimetric Simulation Study

被引：0
|
作者：
Rahimian, J. [1 ]
Bhattasali, O. [1 ]
Girvigian, M. R. [2 ]
机构：
[1] Southern Calif Permanente Med Grp, Los Angeles, CA USA
[2] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3553
引用
收藏
页码：E709 / E709
页数：1
相关论文
共 50 条
  • [21] Stereotactic body radiotherapy for central lung tumors, yes we can!
    Ceder, Yasmin Korzets
    Fenig, Eyal
    Popvtzer, Aron
    Peled, Nir
    Kramer, Mordechai R.
    Saute, Milton
    Bragilovsky, Dima
    Schochat, Tzippy
    Allen, Aaron M.
    RADIATION ONCOLOGY, 2018, 13 : 77
  • [22] Safety of Stereotactic Body Radiotherapy for Central, Ultracentral, and Paramediastinal Lung Tumors
    Daly, Megan
    Novak, Jennifer
    Monjazeb, Arta
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1066 - S1066
  • [23] Stereotactic ablative radiotherapy for small lung tumors with a moderate dose Favorable results and low toxicity
    Duncker-Rohr, V.
    Nestle, U.
    Momm, F.
    Prokic, V.
    Heinemann, F.
    Mix, M.
    Reusch, J.
    Messmer, M. -B.
    Marschner, N.
    Waller, C. F.
    Weber, W. A.
    Grosu, A. -L.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (01) : 33 - 40
  • [24] Adaptive Strategies to Reduce Toxicity of Stereotactic Body Radiotherapy (SBRT) for Large Stage I Lung Tumors
    Dahele, M.
    de Koste, J. R. van Sornsen
    Slotman, B.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S527 - S527
  • [25] Does Histological Subtype Affect Outcomes in Stereotactic Ablative Body Radiotherapy (SABR) for Lung Tumors?
    Allos, B.
    Mascall, S.
    Vreugdenhil, M.
    Watkins, S.
    Stevenson, R.
    Ghafoor, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2179 - S2180
  • [26] Pilot Study of the Safety and Efficacy of Dose Escalation in Stereotactic Body Radiotherapy for Peripheral Lung Tumors
    Mitsuyoshi, Takamasa
    Matsuo, Yukinori
    Shintani, Takashi
    Iizuka, Yusuke
    Ueki, Nami
    Nakamura, Mitsuhiro
    Mizowaki, Takashi
    CLINICAL LUNG CANCER, 2018, 19 (03) : E287 - E296
  • [27] Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations
    Regnery, Sebastian
    Buchele, Carolin
    Weykamp, Fabian
    Pohl, Moritz
    Hoegen, Philipp
    Eichkorn, Tanja
    Held, Thomas
    Ristau, Jonas
    Rippke, Carolin
    Koenig, Laila
    Thomas, Michael
    Winter, Hauke
    Adeberg, Sebastian
    Debus, Juergen
    Klueter, Sebastian
    Hoerner-Rieber, Juliane
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [28] Biologically effective dose and overall survival in stereotactic body radiotherapy for lung tumors
    Osamu Tanaka
    Norihiko Funaguchi
    Sayaka Toyoshi
    Takuya Taniguchi
    Kousei Ono
    Chiyoko Makita
    Masayuki Matsuo
    memo - Magazine of European Medical Oncology, 2020, 13 : 353 - 356
  • [29] Biologically effective dose and overall survival in stereotactic body radiotherapy for lung tumors
    Tanaka, Osamu
    Funaguchi, Orihiko
    Toyoshi, Sayaka
    Taniguchi, Takuya
    Ono, Kousei
    Makita, Chiyoko
    Matsuo, Masayuki
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (03) : 353 - 356
  • [30] Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors
    Nicosia, Luca
    Reverberi, Chiara
    Agolli, Linda
    Marinelli, Luca
    De Sanctis, Vitaliana
    Valeriani, Maurizio
    Osti, Mattia F.
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345